G01N 2800/7014
Vascularisation - angiogenesis
Official title: (Neo)vascularisation - Angiogenesis
G01N2800/7014 (Vascularisation - angiogenesis) appears on 50 US grants and 95 published applications in this corpus.
Search patents in G01N- Granted patents
- 50
- Published applications
- 95
- Assignees
- 71
- Inventors
- 224
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 5 |
| 2013 | 2 | 1 |
| 2014 | 1 | 7 |
| 2015 | 3 | 9 |
| 2016 | 3 | 9 |
| 2017 | 3 | 4 |
| 2018 | 10 | 9 |
| 2019 | 6 | 8 |
| 2020 | 1 | 4 |
| 2021 | 3 | 11 |
| 2022 | 8 | 11 |
| 2023 | 2 | 1 |
| 2024 | 1 | 4 |
| 2025 | 3 | 4 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Artificial intelligence for early cancer detection8 Sep 2026US 12,730,108 B2Regents of the University of Minnesota
- Methods for evaluating angiogenesis21 Apr 2026US 12,607,623 B2Washington University
- Ex vivo tumor angiogenesis model31 Mar 2026US 12,590,298 B2The Regents of the University of California
- Anti-TIE2 antibody and use thereof18 Nov 2025US 12,473,366 B2Pharmabcine Inc.
- Single domain antibody targeting αVβ3 integrin12 Aug 2025US 12,383,634 B2Korea Basic Science Institute
- Methods for Evaluating Angiogenesis14 May 2026US 2026/0133180 A1Washington University
- Animal models and methods of use9 Oct 2025US 2025/0311706 A1Genentech, Inc.
- Angiogenesis inhibiting peptide and use thereof18 Sep 2025US 2025/0288647 A1Seoul National University Hospital
- Plxdc1/plxdc2 activators and their use in the treatment of blood vessel disorders17 Jul 2025US 2025/0230226 A1Atengen, Inc.
- System for measuring metastatic potential of cancer cells and method for measuring metastatic potential of cancer cells by using same19 Jun 2025US 2025/0198987 A1Seoul National University Hospital
Most cited
By later US patents
- Inhibition of angiogenesis13US 8,470,607 B2Morphotek, Inc. · 2013
- Endothelial cell expression patterns10US 7,393,932 B2The Johns Hopkins University · 2008
- Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization8US 11,209,444 B2The Schepens Eye Research Institute, Inc. · 2021
- Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent7US 10,260,097 B2Almac Diagnostics Limited · 2019
- TM4SF1 binding proteins and methods of using same6US 10,745,479 B2Beth Israel Deaconess Medical Center, Inc. · 2020